Acerus Pharmaceuticals Corp — Form D

Acerus Pharmaceuticals Corp of MISSISSAUGA, A6, a company, filed a Form D exempt-offering notice with the SEC on 2014-08-13. The offering totals $2.1M, of which $2.1M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
John K FriedrichsenDirectorMississauga, A6
Stephen K GregoryDirectorMississauga, A6
Ian K IhnatowyczDirectorMississauga, A6
Tom RossiDirectorBuffalo, NY
Jeffrey Lorne ShermanDirectorMississauga, A6
D. Lorne TyrellDirectorMississauga, A6
Nathan BrysonExecutive OfficerMorristown, NJ
Matthew HawkinsExecutive OfficerToronto, A6
Kenneth HowlingExecutive OfficerMississauga, A6
Matthew K PfefferExecutive OfficerMississauga, A6
ROLF K REININGHAUSExecutive OfficerMISSISSAUGA, A6
Tom RossiExecutive OfficerBuffalo, NY
Ian IhnatowyczDirectorVancouver, A1
Matthew K HawkinsExecutive OfficerFORT LEE, NJ
BORYS K CHABURSKYDirectorMISSISSAUGA, A6
ROLF K REININGHAUSDirectorMISSISSAUGA, A6
TOM K ROSSIDirectorMISSISSAUGA, A6
TOM K ROSSIExecutive OfficerMISSISSAUGA, A6
JEFFREY K SHERMANDirectorMISSISSAUGA, A6
DR. NATHAN K BRYSONExecutive OfficerMISSISSAUGA, A6
DR. MICHAEL K BUMBYExecutive OfficerMISSISSAUGA, A6
STEPHEN GREGORYDirectorMISSISSAUGA, A6
JOSEF K VEJVODADirectorMISSISSAUGA, A6
NORMA BEAUCHAMPDirectorMISSISSAUGA, A6
Larry L DavisDirectorPhoenix, AZ

Other filings by this issuer (2)

FiledFormOfferingSold
2016-05-05D$2.0M$2.0M
2011-08-03D$12.0M$6.8M

More